name: Lyme Disease
category: Infectious
description: >
  Lyme disease is a tick-borne infectious disease caused by Borrelia burgdorferi
  and related Borrelia species. It is the most common vector-borne disease in
  North America and Europe. The disease progresses through stages: early localized
  (erythema migrans), early disseminated (multiple erythema migrans, neurological,
  cardiac involvement), and late disseminated (arthritis, chronic neurological).
  Early antibiotic treatment is highly effective, while delayed treatment may lead
  to persistent symptoms.
disease_term:
  preferred_term: Lyme disease
  term:
    id: MONDO:0019632
    label: Lyme disease
parents:
  - Bacterial Infection
  - Tick-Borne Disease
has_subtypes:
  - name: Early Localized Lyme Disease
    description: Initial stage within weeks of tick bite, characterized by erythema migrans and flu-like symptoms.
  - name: Early Disseminated Lyme Disease
    description: Hematogenous spread within weeks to months, with multiple erythema migrans, neurological, or cardiac involvement.
  - name: Late Disseminated Lyme Disease
    description: Months to years after infection, characterized by Lyme arthritis or chronic neurological manifestations.
  - name: Post-Treatment Lyme Disease Syndrome
    description: Persistent symptoms after appropriate antibiotic therapy, occurring in 10-20% of treated patients.
pathophysiology:
  - name: Spirochete Invasion and Dissemination
    description: >
      Borrelia burgdorferi is transmitted through Ixodes tick bites. The spirochete
      disseminates from the skin through the bloodstream to multiple organ systems
      including joints, heart, and nervous system. Surface adhesins like BBK32 and
      decorin-binding proteins (DbpA/DbpB) facilitate tissue colonization.
    evidence:
      - reference: PMID:33669940
        supports: SUPPORT
        snippet: "The clinical manifestations of Lyme disease range from a localized infection, for example, erythema migrans (EM) to a disseminated neurological or rheumatological infection, cardiac involvement, or even chronic disease."
        explanation: Epidemiologic series shows Borrelia disseminates beyond skin to neurologic, rheumatologic, and cardiac sites.
    cell_types:
      - preferred_term: endothelial cell
        term:
          id: CL:0000115
          label: endothelial cell
    biological_processes:
      - preferred_term: cell adhesion
        term:
          id: GO:0007155
          label: cell adhesion
  - name: Autoimmune Activation after Persistent Infection
    description: >
      Prolonged exposure of the host immune system to Borrelia antigens can drive
      post-infectious autoimmunity, with reported triggers of systemic autoimmune
      disease after Lyme borreliosis.
    evidence:
      - reference: PMID:34786243
        supports: SUPPORT
        snippet: "long-term exposure of the host's immune system to spirochetes can contribute to the development of chronic autoimmune disease de novo."
        explanation: Case review links persistent Borrelia exposure to downstream autoimmune disease.
    cell_types:
      - preferred_term: T cell
        term:
          id: CL:0000084
          label: T cell
    biological_processes:
      - preferred_term: immune system process
        term:
          id: GO:0002376
          label: immune system process
  - name: Inflammatory Response and Tissue Damage
    description: >
      The host immune response to Borrelia antigens contributes to tissue damage.
      Spirochetal lipoproteins and peptidoglycan trigger robust innate immune
      activation with production of IL-6, IL-8, TNF, and chemokines (CCL3/CCL4).
      Persistent inflammation in joints may continue even after spirochete clearance.
    evidence:
      - reference: PMID:37407232
        supports: SUPPORT
        snippet: "Aspiration of the left knee joint revealed a white cell count of 21.0Ã—109/L (83% neutrophils) with negative Gram stain and culture. However, Lyme PCR was positive and accompanied by serologies consistent with Lyme arthritis."
        explanation: Lyme arthritis joint fluid shows marked neutrophilic inflammation despite negative cultures, consistent with immune-driven damage.
    cell_types:
      - preferred_term: neutrophil
        term:
          id: CL:0000775
          label: neutrophil
      - preferred_term: macrophage
        term:
          id: CL:0000235
          label: macrophage
      - preferred_term: T cell
        term:
          id: CL:0000084
          label: T cell
    biological_processes:
      - preferred_term: inflammatory response
        term:
          id: GO:0006954
          label: inflammatory response
phenotypes:
  - name: Erythema Migrans
    category: Dermatologic
    frequency: VERY_FREQUENT
    description: Characteristic expanding circular rash at the site of tick bite, often with central clearing (bull's-eye appearance). Present in 70-80% of cases.
    phenotype_term:
      preferred_term: Erythema migrans
      term:
        id: HP:0031180
        label: Erythema migrans
    evidence:
      - reference: PMID:33669940
        supports: SUPPORT
        snippet: "Results: In total, 1005 patients were enrolled with the following prevalence of clinical syndromes: erythema migrans (EM), 945 (94.02%); Lyme arthritis, 32 (3.18%); neuroborreliosis, 23 (2.28%); Lyme carditis, 4 (0.39%); and acrodermatitis, 1 (0.09%)."
        explanation: Large Lithuanian cohort confirms erythema migrans as the dominant presentation.
  - name: Fatigue
    category: Constitutional
    frequency: VERY_FREQUENT
    description: Profound fatigue is common in all stages of Lyme disease and may persist in post-treatment Lyme disease syndrome.
    phenotype_term:
      preferred_term: Fatigue
      term:
        id: HP:0012378
        label: Fatigue
    evidence:
      - reference: PMID:33669940
        supports: SUPPORT
        snippet: "Clinical symptoms were as follows: arthralgia (33.2%), general weakness (19%), head pain (13.1%), myalgia (11.2%), fever (6.2%), joint swelling (5.9%), head dizziness (5.1%), nervus facialis neuropathy (2.4%), and radiculitis (2.0%)."
        explanation: Population data list general weakness among frequent symptoms of Lyme disease.
  - name: Arthralgia
    category: Musculoskeletal
    frequency: FREQUENT
    description: Joint pain, particularly affecting large joints such as the knee, commonly precedes frank arthritis.
    phenotype_term:
      preferred_term: Arthralgia
      term:
        id: HP:0002829
        label: Arthralgia
    evidence:
      - reference: PMID:33669940
        supports: SUPPORT
        snippet: "Clinical symptoms were as follows: arthralgia (33.2%), general weakness (19%), head pain (13.1%), myalgia (11.2%), fever (6.2%), joint swelling (5.9%), head dizziness (5.1%), nervus facialis neuropathy (2.4%), and radiculitis (2.0%)."
        explanation: Arthralgia was reported in one-third of patients in a large endemic cohort.
  - name: Facial Palsy
    category: Neurological
    frequency: OCCASIONAL
    description: Unilateral or bilateral facial nerve palsy (Bell's palsy) in early disseminated disease, occurring in approximately 5% of untreated patients.
    phenotype_term:
      preferred_term: Facial palsy
      term:
        id: HP:0010628
        label: Facial palsy
    evidence:
      - reference: PMID:33669940
        supports: SUPPORT
        snippet: "The main symptoms were the following: nervus facialis neuropathy (47.8%), myalgia (39%), head pain (26%), and radiculitis (21%)."
        explanation: Neuroborreliosis cases frequently manifested facial nerve palsy.
  - name: Arthritis
    category: Musculoskeletal
    frequency: FREQUENT
    description: Inflammatory arthritis, typically monoarticular or oligoarticular, affecting large joints especially the knee. Occurs in approximately 60% of untreated patients.
    phenotype_term:
      preferred_term: Arthritis
      term:
        id: HP:0001369
        label: Arthritis
    evidence:
      - reference: PMID:33669940
        supports: SUPPORT
        snippet: "Lyme arthritis mainly manifested among middle-aged women as an oligoarthritis, mostly affecting the knee joint."
        explanation: Cohort study documents oligoarticular knee-predominant Lyme arthritis.
  - name: Atrioventricular Block
    category: Cardiac
    frequency: OCCASIONAL
    description: Cardiac involvement including AV block (first, second, or third degree) and myocarditis. Lyme carditis occurs in 1-5% of untreated patients.
    phenotype_term:
      preferred_term: Atrioventricular block
      term:
        id: HP:0001678
        label: Atrioventricular block
    evidence:
      - reference: PMID:37234726
        supports: SUPPORT
        snippet: "the most common clinical manifestation is AV block, which can be acute in onset and can rapidly progress to complete heart block."
        explanation: Case report and review emphasize AV block as the hallmark of Lyme carditis.
biochemical:
  - name: Anti-Borrelia Antibodies (IgM/IgG)
    presence: Detected
    context: Two-tier testing with ELISA screening and Western blot confirmation; antibodies may take 2-4 weeks to develop
  - name: Elevated ESR/CRP
    presence: Elevated
    context: Markers of systemic inflammation, especially in disseminated disease
  - name: CSF Pleocytosis
    presence: Elevated
    context: In neuroborreliosis, lymphocytic pleocytosis with elevated protein and intrathecal antibody production
genetic:
  - name: HLA-DR4
    association: Susceptibility
    notes: HLA-DRB1*04 alleles associated with antibiotic-refractory Lyme arthritis and autoimmune mechanisms
environmental:
  - name: Tick Exposure
    notes: Ixodes scapularis (deer tick) in eastern North America, I. pacificus in western North America, I. ricinus in Europe
  - name: Geographic Location
    notes: Endemic areas include northeastern and upper midwestern United States, and parts of Europe and Asia
  - name: Seasonal Exposure
    notes: Peak transmission during late spring and summer months (May-August) when nymphal ticks are active
  - name: Outdoor Activities
    notes: Risk factors include hiking, camping, gardening, and activities in wooded or grassy areas
treatments:
  - name: Oral Doxycycline
    description: >
      First-line treatment for early localized and early disseminated Lyme disease
      in adults. Typical dose is 100mg twice daily for 10-21 days. Also provides
      prophylaxis for tick bites in endemic areas.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
    evidence:
      - reference: PMID:17029130
        supports: SUPPORT
        snippet: "Tables list the doses and durations of antimicrobial therapy recommended for treatment and prevention of Lyme disease"
        explanation: IDSA guidelines provide evidence-based antibiotic treatment recommendations for Lyme disease.
  - name: Oral Amoxicillin
    description: >
      Alternative first-line agent for early Lyme disease, preferred in children
      under 8 years and pregnant women. Typical dose is 500mg three times daily.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
    evidence:
      - reference: PMID:17176487
        supports: SUPPORT
        snippet: "We describe a favorable outcome in a 42-year-old woman who developed Lyme disease in the third trimester and was treated with a full course of oral amoxicillin."
        explanation: Case report in pregnancy shows successful treatment with amoxicillin.
  - name: Intravenous Ceftriaxone
    description: >
      Recommended for neurological Lyme disease (neuroborreliosis), Lyme carditis
      with high-degree AV block, and some cases of Lyme arthritis. Duration
      typically 14-28 days.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
    evidence:
      - reference: PMID:37692616
        supports: SUPPORT
        snippet: "The patient's symptoms resolved quickly with a four-day inpatient course of IV ceftriaxone followed by 10 days of oral doxycycline."
        explanation: Neuroborreliosis case improved with intravenous ceftriaxone then doxycycline.
datasets:
